LAVAL, QC, July 7, 2026 /CNW/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2026 financial results after market close on Wednesday, July 29, 2026. Bausch Health will host a live conference call and webcast at 5:00 p.m. U.S. EDT to discuss results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
Conference Call Details
Date: Wednesday, July 29, 2026
Time: 5:00 p.m. U.S. EDT
Webcast:
A replay of the conference call will be available on the Investor Relations website.
About Bausch HealthBausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit and connect with us on .
Investor Contact: Media Contact: | Garen Sarafian Katie Savastano | (877) 281-6642 (toll-free) (908) 541-3785 | BHC-FINANCIAL |
SOURCE Bausch Health Companies Inc.